United States · FDA National Drug Code directory

Anagallis Arvensis

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
63545-980_2b4a8b5e-872a-3c78-e063-6394a90a194d
Product NDC
63545-980
Form
PELLET
Composition / generic term
Anagallis Arvernsis
Labeler
Hahnemann Laboratories, Inc.
Marketing category
UNAPPROVED HOMEOPATHIC
Marketing start / end (source format)
20201116
Source listing expiry
20261231

Source-listed ingredients

  • ANAGALLIS ARVENSIS WHOLE — 12 [hp_C]/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 200 PELLET in 1 VIAL, GLASS (63545-980-01) · 63545-980-01
  • 1200 PELLET in 1 BOTTLE, GLASS (63545-980-02) · 63545-980-02
  • 4000 PELLET in 1 BOTTLE, GLASS (63545-980-03) · 63545-980-03

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
Anagallis Arvensis — United States | Molindra Medicines